相似文献
1
Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.
Biochem J. 1984 Nov 1;223(3):599-605. doi: 10.1042/bj2230599.
2
The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.
Biochem J. 1984 Nov 1;223(3):607-15. doi: 10.1042/bj2230607.
3
Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
Thromb Haemost. 1985 Jun 24;53(3):396-400.
4
Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa.
Biochemistry. 1985 Dec 31;24(27):8064-9. doi: 10.1021/bi00348a034.
5
Comparative interactions of factor IX and factor IXa with human platelets.
J Biol Chem. 1989 Feb 25;264(6):3244-51.
6
The interactions of factors X and IX with phospholipid.
Thromb Res. 1989 May 15;54(4):261-8. doi: 10.1016/0049-3848(89)90084-4.
7
Molecular interactions of the intrinsic activation complex of coagulation: binding of native and activated human factors IX and X to defined phospholipid vesicles.
Biochim Biophys Acta. 1987 Feb 20;923(2):176-86. doi: 10.1016/0304-4165(87)90002-x.
8
Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
Biochem J. 2004 Aug 1;381(Pt 3):779-94. doi: 10.1042/BJ20031748.
9
Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Biochemistry. 1998 Feb 10;37(6):1671-9. doi: 10.1021/bi971591h.
10
Kinetics of coagulation factor X activation by platelet-bound factor IXa.
Biochemistry. 1990 Mar 13;29(10):2606-11. doi: 10.1021/bi00462a025.
引用本文的文献
1
Coagulation factor VIII: biological basis of emerging hemophilia A therapies.
Blood. 2024 Nov 21;144(21):2185-2197. doi: 10.1182/blood.2023023275.
2
Phosphatidylserine Regulation of Coagulation Proteins Factor IXa and Factor VIIIa.
J Membr Biol. 2022 Dec;255(6):733-737. doi: 10.1007/s00232-022-00265-7. Epub 2022 Sep 13.
3
SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.
Blood Adv. 2022 Jun 14;6(11):3240-3254. doi: 10.1182/bloodadvances.2021005874.
4
Haemophilia.
Nat Rev Dis Primers. 2021 Jun 24;7(1):45. doi: 10.1038/s41572-021-00278-x.
5
A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice.
Blood. 2021 Oct 7;138(14):1258-1268. doi: 10.1182/blood.2020010331.
6
Activated protein C has a regulatory role in factor VIII function.
Blood. 2021 May 6;137(18):2532-2543. doi: 10.1182/blood.2020007562.
7
Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine.
Blood. 2015 Sep 3;126(10):1237-44. doi: 10.1182/blood-2015-01-620245. Epub 2015 Jul 10.
8
A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.
J Biol Chem. 2013 Sep 6;288(36):26105-26111. doi: 10.1074/jbc.M113.500884. Epub 2013 Jul 24.
9
Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
Biochem J. 2004 Aug 1;381(Pt 3):779-94. doi: 10.1042/BJ20031748.
10
Surface-loop residue Lys316 in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition.
Biochem J. 2000 Sep 15;350 Pt 3(Pt 3):701-7.
本文引用的文献
1
Interaction of prothrombin and its fragments with monolayers containing phosphatidylserine. 1. Binding of prothrombin and its fragment I to phosphatidylserine-containing monolayers.
Biochemistry. 1980 Jul 22;19(15):3434-9. doi: 10.1021/bi00556a005.
2
The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
Thromb Haemost. 1981 Jun 30;45(3):237-41.
3
Phospholipid vesicle aggregation: effect of monovalent and divalent ions.
Biochemistry. 1982 Apr 27;21(9):2127-33. doi: 10.1021/bi00538a022.
4
Blood coagulation.
Annu Rev Biochem. 1980;49:765-811. doi: 10.1146/annurev.bi.49.070180.004001.
5
Activation of human coagulation factor VIII by activated factor X, the common product of the intrinsic and the extrinsic pathway of blood coagulation.
Thromb Haemost. 1982 Apr 30;47(2):96-100.
6
Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles.
Biochem J. 1981 Oct 15;200(1):161-7. doi: 10.1042/bj2000161.
7
Human factor VIII procoagulant activity and phospholipid interaction.
Biochim Biophys Acta. 1981 Nov 18;678(1):132-6. doi: 10.1016/0304-4165(81)90056-8.
8
The role of phospholipid and factor VIIIa in the activation of bovine factor X.
J Biol Chem. 1981 Apr 10;256(7):3433-42.
9
Pathways in the activation of human coagulation factor X.
Biochem J. 1980 Mar 1;185(3):647-58. doi: 10.1042/bj1850647.
10
A kinetic evaluation of activated bovine blood coagulation factor IX toward synthetic substrates.
J Biol Chem. 1980 Jun 10;255(11):5336-41.
Zotero 插件